INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 78 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $210,000 | +72.1% | 10,000 | 0.0% | 0.11% | +35.4% |
| Q1 2020 | $122,000 | -17.0% | 10,000 | 0.0% | 0.08% | +8.2% |
| Q4 2019 | $147,000 | +9.7% | 10,000 | 0.0% | 0.07% | 0.0% |
| Q3 2019 | $134,000 | -18.3% | 10,000 | 0.0% | 0.07% | -19.8% |
| Q2 2019 | $164,000 | -4.1% | 10,000 | 0.0% | 0.09% | -9.0% |
| Q1 2019 | $171,000 | +25.7% | 10,000 | 0.0% | 0.10% | +12.4% |
| Q4 2018 | $136,000 | -52.4% | 10,000 | 0.0% | 0.09% | -42.9% |
| Q3 2018 | $286,000 | -41.0% | 10,000 | -50.0% | 0.16% | +13.9% |
| Q2 2018 | $485,000 | +129.9% | 20,000 | +100.0% | 0.14% | +14.2% |
| Q1 2018 | $211,000 | -45.1% | 10,000 | -50.0% | 0.12% | +14.3% |
| Q4 2017 | $384,000 | -5.9% | 20,000 | 0.0% | 0.10% | -12.5% |
| Q3 2017 | $408,000 | +155.0% | 20,000 | +100.0% | 0.12% | +25.0% |
| Q2 2017 | $160,000 | +13.5% | 10,000 | 0.0% | 0.10% | +10.3% |
| Q1 2017 | $141,000 | – | 10,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |